Chau et al developed a simple prognostic index for evaluating patients with carcinomas of the esophagus or stomach that are locally advanced or metastatic. This can help identify patients who may benefit from more aggressive management. The authors are from Royal Marsden Hospital in London.
Patient selection:
(1) cancer of the esophagus, esophagogastric junction or stomach of any histologic type
(2) locally advanced or metastatic
Parameters:
(1) performance status
(2) liver metastases
(3) peritoneal metastases
(4) serum alkaline phosphatase
Parameter |
Finding |
Points |
---|---|---|
ECOG performance status |
0 or 1 |
0 |
|
2, 3 or 4 |
1 |
liver metastases |
none |
0 |
|
present |
1 |
peritoneal metastases |
none |
0 |
|
present |
1 |
serum alkaline phosphatase |
< 100 U/L |
0 |
|
>= 100 U/L |
1 |
where:
• The method and normal reference range for serum alkaline phosphatase was not listed.
index score =
= SUM(points for all 4 parameters)
Interpretation:
• minimum index: 0
• maximum index: 4
• The higher the score, the worse the prognosis.
Index |
Risk Group |
Median Survival |
1 Year Survival |
---|---|---|---|
0 |
good |
12 months |
49% |
1 or 2 |
moderate |
7 months |
26% |
3 or 4 |
poor |
4 months |
11% |
from Figure 2, page 2400, survival numbers rounded
Purpose: To evaluate a patient with locally advanced or metastatic cancer of the esophagus or stomach using the prognostic index of Chau et al.
Specialty: Hematology Oncology, Surgery, general, Gastroenterology
Objective: severity, prognosis, stage
ICD-10: C15, C16,